Samuel Eugene Lynch insider trades: Biomimetic Therapeutics (BMTI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Samuel reports to the SEC
Open-market buys and sales
30 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 30, 2012 | BMTI | ↑ Buy | 70,000 | $2.41 | $169K | Direct | Mar 30, 2012 (0d) |
| Mar 23, 2012 | BMTI | ↑ Buy | 12,700 | $2.35 | $30K | Direct | Mar 28, 2012 (5d) |
| Mar 23, 2012 | BMTI | ↑ Buy | 450 | $2.35 | $1K | By Wife | Mar 28, 2012 (5d) |
| Jun 30, 2011 | GRNB | ↑ Buy | 1,518 | $2.62 | $4K | Direct | Jul 1, 2011 (1d) |
| May 18, 2011 | BMTI | ↑ Buy | 13,000 | $7.87 | $102K | Direct | May 19, 2011 (1d) |
| Apr 12, 2011 | GRNB | ↑ Buy | 192 | $2.79 | $536 | Direct | Apr 13, 2011 (1d) |
| Dec 29, 2009 | BMTI | ↓ Sell | 6,000 | $11.43 | $69K | Direct | Dec 30, 2009 (1d) |
| Dec 15, 2009 | BMTI | ↓ Sell | 6,000 | $12.18 | $73K | Direct | Dec 16, 2009 (1d) |
| Dec 3, 2009 | BMTI | ↓ Sell | 6,000 | $11.09 | $67K | Direct | Dec 4, 2009 (1d) |
| Nov 17, 2009 | BMTI | ↓ Sell | 6,000 | $11.72 | $70K | Direct | Nov 18, 2009 (1d) |
| Nov 5, 2009 | BMTI | ↓ Sell | 6,000 | $11.66 | $70K | Direct | Nov 6, 2009 (1d) |
| Oct 21, 2009 | BMTI | ↓ Sell | 9,000 | $14.03 | $126K | Direct | Oct 23, 2009 (2d) |
| Oct 6, 2009 | BMTI | ↓ Sell | 7,500 | $12.14 | $91K | Direct | Oct 7, 2009 (1d) |
| Sep 24, 2009 | BMTI | ↓ Sell | 9,000 | $13.03 | $117K | Direct | Sep 25, 2009 (1d) |
| Sep 10, 2009 | BMTI | ↓ Sell | 6,000 | $12.00 | $72K | Direct | Sep 11, 2009 (1d) |
| Aug 26, 2009 | BMTI | ↓ Sell | 6,000 | $11.59 | $70K | Direct | Aug 27, 2009 (1d) |
| Aug 13, 2009 | BMTI | ↓ Sell | 6,000 | $10.82 | $65K | Direct | Aug 14, 2009 (1d) |
| Jul 30, 2009 | BMTI | ↓ Sell | 3,000 | $10.09 | $30K | Direct | Jul 31, 2009 (1d) |
| Jul 29, 2009 | BMTI | ↓ Sell | 3,000 | $9.84 | $30K | Direct | Jul 31, 2009 (2d) |
| Jul 17, 2009 | BMTI | ↓ Sell | 3,000 | $9.80 | $29K | Direct | Jul 20, 2009 (3d) |
| Jul 16, 2009 | BMTI | ↓ Sell | 3,000 | $9.87 | $30K | Direct | Jul 20, 2009 (4d) |
| Jul 1, 2009 | BMTI | ↓ Sell | 3,000 | $9.36 | $28K | Direct | Jul 2, 2009 (1d) |
| Jun 30, 2009 | BMTI | ↓ Sell | 3,000 | $9.26 | $28K | Direct | Jul 2, 2009 (2d) |
| Jun 17, 2009 | BMTI | ↓ Sell | 6,000 | $9.01 | $54K | Direct | Jun 18, 2009 (1d) |
| Jun 4, 2009 | BMTI | ↓ Sell | 6,000 | $9.04 | $54K | Direct | Jun 5, 2009 (1d) |
| Jan 29, 2009 | BMTI | ↓ Sell | 50,000 | $9.63 | $481K | Direct | Jan 29, 2009 (0d) |
| Mar 28, 2008 | BMTI | ↑ Buy | 5,400 | $8.95 | $48K | Direct | Apr 1, 2008 (4d) |
| Feb 14, 2007 | BMTI | ↓ Sell | 236,239 | $17.15 | $4.1M | Direct | Feb 14, 2007 (0d) |
| May 12, 2006 | BMTI | ↑ Buy | 7,400 | $8.00 | $59K | Direct | May 15, 2006 (3d) |
| May 12, 2006 | BMTI | ↑ Buy | 5,100 | $8.00 | $41K | By Spouse | May 15, 2006 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Samuel Eugene Lynch's insider trades
Samuel Eugene Lynch is President and CEO at Biomimetic Therapeutics (BMTI). Since May 12, 2006, Samuel has reported 9 open-market purchases worth $455K and 21 sales worth $5.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (10 filings), gifts (5 filings), option exercises (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BMTI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.